Manage episode 302586845 series 2712770
Niladri Mukherjee, head of portfolio strategy at Merrill Lynch Bank of America Private Bank, thinks that equities will grind higher from current levels, but that progress will be based on a 'different playbook' driven by rising corporate earnings and narrower moves that force investors to dig into the numbers -- to 'get micro' looking at valuation opportunities -- rather than relying on the rising tide of indexes to carry them forward. Also on the show, Steve Seedhouse, managing director of biotechnology equity research for Raymond James discusses the long-term impacts of Covid on biotech stocks, noting that the virus has become endemic -- it will be with us indefinitely, requiring treatments in the future to cover any and all variants -- and that status changes the prospects for businesses responding to it. He also covers the emerging biotech processes that he believes have significant potential. Also on the show, James Thom, manager of the closed-end India Fund, discusses the country's remarkable growth rate during recovery and the opportunities it presents, and Danny Sullivan, director for risk for Verus Investments, talks about how investors need to consider inflation in terms of the danger it holds to their portfolio rather than as simply a threat to the market.